Galliprost - Democratisation of PET imaging technology for prostate cancer patients through smart radiochemistry
- Submitting institution
-
King's College London
- Unit of assessment
- 12 - Engineering
- Summary impact type
- Technological
- Request cross-referral to
- -
- Is this case study continued from a case study submitted in 2014?
- No
- Underpinning research subjects
-
- Medicinal And Biomolecular Chemistry
- Organic Chemistry
- Clinical Sciences
3. References to the research
5. Sources to corroborate the impact
Additional contextual information
Grant funding
| Grant number |
Value of grant |
| EP/S019901/1 |
£5,334,387 |
| EP/S032789/1 |
£6,437,106 |
| 212885/Z/18/Z |
£896,850 |
| C7893/A26233 |
£542,876 |
| EP/R512667/1 |
£49,607 |
| 203148/Z/16/Z |
£12,100,395 |
| n/a |
£5,349,326 |
| MC_PC_15031 |
£75,903 |
| C48390/A21153 |
£501,903 |
| MC_PC_14105 |
£99,831 |
| C1519/A16463 |
£4,197,760 |
- Formal partners
-
- GE Healthcare
- AstraZeneca
- Clarity Pharmaceuticals
- GlaxoSmithKline plc
- Lipomedix Pharmaceuticals Ltd
- Theragnostics Ltd
- Bicycle Therapeutics Ltd
- Cytiva Europe
- Imaging Equipment Ltd
- NanoMab
- University of Birmingham
- Cell Therapy Catapult
- European Commission
- LIFNano Therapeutics
- National Physical Laboratory
- University of Bristol
- GSTT
- Funding programmes
-
- Programme Grants
- Programme Grant
- Multi-User Equipment Grant
- Research Grant
- EPSRC
- Research Grant
- Research Grant
- Research Grant
- Research Grant
- Research Grant
- CRUK
- Name of funders
-
- EPSRC
- EPSRC
- Wellcome Trust
- CRUK
- EPSRC
- Wellcome Trust
- NIHR
- MRC
- CRUK
- MRC
- CRUK
- Researcher ORCIDs
-
- 0000-0002-7904-8335
- 0000-0002-1438-2674
- 0000-0002-7904-8335
- 0000-0002-6497-6681
- 0000-0002-2516-5288
- 0000-0001-9892-9640
- 0000-0002-2726-3383
- 0000-0003-0431-0535
- 0000-0002-3349-7346
- 0000-0001-6290-1590
- 0000-0001-8389-9012
- 0000-0001-6290-1590
- 0000-0002-3349-7346
- 0000-0003-0431-0535
- 0000-0001-8389-9012
- 0000-0002-9475-2873
- 0000-0001-6290-1590
- 0000-0002-9475-2873
- 0000-0002-6093-1654
- 0000-0002-6497-6681
- 0000-0002-3349-7346
- 0000-0001-6290-1590
- 0000-0003-1065-3008
- 0000-0002-5214-7421
- 0000-0003-2811-2509
- 0000-0003-4801-7066
- 0000-0001-8389-9012
- 0000-0002-2690-5495
- 0000-0001-9530-4848
- 0000-0002-4612-6982
- 0000-0002-2726-3383
- 0000-0002-4707-7318
- 0000-0001-6107-3009
- 0000-0002-6093-1654
- 0000-0002-3766-3815
- 0000-0002-7266-2084
- 0000-0003-4299-1941
- 0000-0001-6290-1590
- 0000-0002-2321-8091
- 0000-0002-8732-8134
- 0000-0001-8389-9012
- 0000-0003-1794-0456
- 0000-0003-3361-1337
- 0000-0002-5277-8530
- 0000-0001-5702-4220
- 0000-0003-3361-1337
- 0000-0001-8389-9012
- 0000-0001-6290-1590
- 0000-0003-4801-7066
- 0000-0001-6290-1590
- 0000-0002-3300-0520
- 0000-0001-6290-1590
- 0000-0002-1438-2674
- 0000-0003-0431-0535
- 0000-0002-8732-8134
- 0000-0001-6290-1590
- 0000-0002-2321-8091
- 0000-0001-6290-1590
- 0000-0002-8732-8134
